Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress.
The aim of the present study was to investigate whether and which cardiac growth factors are involved in human hypertrophy, whether growth factor synthesis is influenced by overload type and/or by the adequacy of the hypertrophy, and the relationships between cardiac growth factor formation and ventricular function. Cardiac growth factor formation was assessed by measuring aorta-coronary sinus concentration gradient in patients with isolated aortic stenosis (n=26) or regurgitation (n=15) and controls (n=12). Gene expression and cellular localization was investigated in ventricular biopsies using reverse transcriptase-polymerase chain reaction and in situ hybridization. Cardiac hypertrophy with end-systolic wall stress <90 kdyne/cm2 was associated with a selective increased formation of insulin-like growth factor (IGF)-I in aortic regurgitation and of IGF-I and endothelin (ET)-1 in aortic stenosis. mRNA levels for IGF-I and preproET-1 were elevated and mainly expressed in cardiomyocytes. At stepwise analysis, IGF-I formation was correlated to the mean velocity of circumferential fiber shortening (r=0.86, P<0.001) and ET-1 formation to relative wall thickness (r=0.82, P<0. 001). When end-systolic wall stress was >90 kdyne/cm2, IGF-I and ET-1 synthesis by cardiomyocytes was no longer detectable, and only angiotensin (Ang) II was generated, regardless of the type of overload. The mRNA level for angiotensinogen was high, and the mRNA was exclusively expressed in the interstitial cells. Ang II formation was positively correlated to end-systolic stress (r=0.89, P<0.001) and end-diastolic stress (r=0.84, P<0.001). Multivariate stepwise analysis selected end-systolic stress as the most predictive variable and left ventricular end-diastolic pressure as the independent variable for Ang II formation (r=0.93, P<0.001). In conclusion, the present results indicate that the course of human left ventricular hypertrophy is characterized by the participation of different cardiac growth factors that are selectively related both to the type of hemodynamic overload and to ventricular function.
Serneri
G G
GG
Clinica Medica Generale e Cardiologia, University of Florence, Italy.
Modesti
P A
PA
Boddi
M
M
Cecioni
I
I
Paniccia
R
R
Coppo
M
M
Galanti
G
G
Simonetti
I
I
Vanni
S
S
Papa
L
L
Bandinelli
B
B
Migliorini
A
A
Modesti
A
A
Maccherini
M
M
Sani
G
G
Toscano
M
M
D000368:Aged; D000809:Angiotensins / Q000097:blood; D006332:Cardiomegaly / Q000097:blood / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000503:physiopathology; D004452:Echocardiography; D016232:Endothelins / Q000097:blood; D006133:Growth Substances / Q000097:blood / Q000378:metabolism*; D006321:Heart / Q000503:physiopathology; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008875:Middle Aged; D009200:Myocardial Contraction / Q000502:physiology; D009206:Myocardium / Q000378:metabolism*; D009693:Nucleic Acid Hybridization; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013314:Stress, Mechanical
D000809:Angiotensins; D016232:Endothelins; D006133:Growth Substances; D007334:Insulin-Like Growth Factor I